Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Naftidrofuryl for dementia

Información

DOI:
https://doi.org/10.1002/14651858.CD002955.pub4Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 diciembre 2011see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Demencia y trastornos cognitivos

Copyright:
  1. Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • DongHao Lu

    Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China

  • Huan Song

    Department of Medical Epidemiology and Biostatics, Karolinska Institute, Stockholm, Sweden

  • Zilong Hao

    Department of Neurology, West China Hospital, Sichuan University, Chengdu, China

  • Taixiang Wu

    Correspondencia a: Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence‐Based Medicine Centre, INCLEN Resource and Training Centre, West China Hospital, Sichuan University, Chengdu, China

    [email protected]

  • Jenny McCleery

    Cochrane Dementia and Cognitive Improvement Group, University of Oxford, Oxford, UK

Contributions of authors

TW: all correspondence; Drafting of review.
DL: drafting of review; extraction of data; data entry into RevMan; selection of trials for inclusion/exclusion; interpretation of data analyses.
HS: search for trials; extraction of data; selection of trials for inclusion/exclusion; obtaining copies of trial reports.
ZH: search for trials; selection of trials for inclusion/exclusion.
JMcC: contributed to design of analysis and drafting of review.
Peter Smith, Clement Loy and Dorothy Tin Niam (Milly Wong) prepared the original protocol

Sources of support

Internal sources

  • Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.

External sources

  • No sources of support supplied

Declarations of interest

All the analyses and interpretation reflect the opinions of the authors; no pharmaceutical company was involved in the analysis or interpretation of data, or in the writing of this systematic review.

Acknowledgements

We are grateful to Peter Smith, Clement Loy and Dorothy Tin Niam (Milly Wong), who prepared the original protocol for this review. We thank the Cochrane Dementia and Cognitive Improvement Group for their kind help and important comments on preparing this manuscript.

Version history

Published

Title

Stage

Authors

Version

2011 Dec 07

Naftidrofuryl for dementia

Review

DongHao Lu, Huan Song, Zilong Hao, Taixiang Wu, Jenny McCleery

https://doi.org/10.1002/14651858.CD002955.pub4

2008 Apr 23

Naftidrofuryl for dementia

Protocol

Huan Song, DongHao Lv, Zilong Hao, Taixiang Wu

https://doi.org/10.1002/14651858.CD002955.pub3

2001 Jan 22

Naftidrofuryl for cognitive impairment

Protocol

Peter Smith, Clement Loy, M Wong, Dorothy Tin Niam (Milly Wong)

https://doi.org/10.1002/14651858.CD002955

Differences between protocol and review

In the Background, the prevalence figures for dementia have been updated. The sections on Data collection and analysis and Methods of the review have also been expanded.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.